These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8070008)

  • 21. Topoisomerase I activity and cellular response to radiation in Chinese hamster cells.
    Zanier R; De Salvia R; Fiore M; Degrassi F
    Int J Radiat Biol; 1996 Sep; 70(3):251-9. PubMed ID: 8800196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.
    Del Bino G; Darzynkiewicz Z
    Cancer Res; 1991 Feb; 51(4):1165-9. PubMed ID: 1997159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.
    Godard T; Deslandes E; Sichel F; Poul JM; Gauduchon P
    Mutat Res; 2002 Sep; 520(1-2):47-56. PubMed ID: 12297143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
    Riou JF; Grondard L; Petitgenet O; Abitbol M; Lavelle F
    Biochem Pharmacol; 1993 Sep; 46(5):851-61. PubMed ID: 8396937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine.
    Ferguson LR; Whiteside G; Holdaway KM; Baguley BC
    Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sister-chromatid exchanges (SCE) induction by inhibitors of DNA topoisomerases in cultured human lymphocytes.
    Ribas G; Xamena N; Creus A; Marcos R
    Mutat Res; 1996 Jul; 368(3-4):205-11. PubMed ID: 8692226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells.
    Suzuki H; Ikeda T; Yamagishi T; Nakaike S; Nakane S; Ohsawa M
    Mutat Res; 1995 May; 328(2):151-61. PubMed ID: 7739599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novobiocin, nalidixic acid, etoposide, and 4'-(9-acridinylamino)methanesulfon-m-anisidide effects on G2 and mitotic Chinese hamster ovary cell progression.
    Rowley R; Kort L
    Cancer Res; 1989 Sep; 49(17):4752-7. PubMed ID: 2474373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis.
    Hasinoff BB; Chee GL; Thampatty P; Allan WP; Yalowich JC
    Anticancer Drugs; 1999 Jan; 10(1):47-54. PubMed ID: 10194547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: detection of DNA strand breaks by flow cytometry using the in situ nick translation assay.
    Gorczyca W; Melamed MR; Darzynkiewicz Z
    Toxicol Lett; 1993 Apr; 67(1-3):249-58. PubMed ID: 8383887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis.
    Voigt W; Matsui S; Yin MB; Burhans WC; Minderman H; Rustum YM
    Anticancer Res; 1998; 18(5A):3499-505. PubMed ID: 9858931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines.
    Chatterjee S; Cheng MF; Trivedi D; Petzold SJ; Berger NA
    Cancer Commun; 1989; 1(6):389-94. PubMed ID: 2562007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of diplochromosomes in mammalian cells by inhibitors of topoisomerase II.
    Sumner AT
    Chromosoma; 1998 Dec; 107(6-7):486-90. PubMed ID: 9914381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of sister chromatid exchanges by inhibitors of topoisomerases.
    Lim M; Liu LF; Jacobson-Kram D; Williams JR
    Cell Biol Toxicol; 1986 Dec; 2(4):485-94. PubMed ID: 2855799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH; Andersson BS; Nelson JA
    Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
    Sullivan DM; Eskildsen LA; Groom KR; Webb CD; Latham MD; Martin AW; Wellhausen SR; Kroeger PE; Rowe TC
    Mol Pharmacol; 1993 Feb; 43(2):207-16. PubMed ID: 8094226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.
    Utsugi T; Mattern MR; Mirabelli CK; Hanna N
    Cancer Res; 1990 May; 50(9):2636-40. PubMed ID: 2158396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y; Kerrigan D; Schwartz RE; Swack JA; McCurdy A
    Cancer Res; 1986 Jun; 46(6):3075-81. PubMed ID: 3009009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of sister chromatid exchange by 3-aminobenzamide is not modulated by topoisomerases or proteases.
    Morgan WF; Doida Y; Fero ML; Guo XC; Shadley JD
    Environ Mutagen; 1986; 8(4):487-93. PubMed ID: 3015582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.